We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks Feedback on Proposal to Reclassify HIV Tests
FDA Seeks Feedback on Proposal to Reclassify HIV Tests
The FDA is planning to reclassify HIV viral load monitoring tests from high-risk class III devices requiring premarket agency approval into lower-risk class II devices requiring special controls and a premarket notification.